Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Acadia Pharmaceuticals
Acadia Pharmaceuticals
(ACAD)
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Sorrento Valley, San Diego, California.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Nuplazid
Pimavanserin
2016-04-29
2024-2038
Parkinson disease
,
Hallucinations
,
Schizophrenia spectrum and other psychotic disorders
Daybue
Trofinetide
2023-03-10
2032-2040
Rett syndrome
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Pimavanserin
alzheimer disease
,
aggression
,
impulse control disruptive and conduct disorders
,
psychomotor agitation
,
hallucinations
,
schizophrenia
,
depression
,
depressive disorder
,
major depressive disorder
,
autistic disorder
,
autism spectrum disorder
,
pervasive child development disorders
,
dementia
,
parkinson disease
,
psychotic disorders
,
mental disorders
,
neurodegenerative diseases
,
sleep initiation and maintenance disorders
,
post-traumatic stress disorders
,
traumatic stress disorders
Trofinetide
brain injuries
,
traumatic brain injuries
,
brain concussion
,
post-concussion syndrome
,
fragile x syndrome
,
syndrome
,
rett syndrome
Fluorodopa f-18
breast neoplasms
Glutamic acid
neoplasms
,
non-small-cell lung carcinoma
,
lung neoplasms
,
melanoma
,
uveal melanoma
Carbetocin
high-risk pregnancy
,
hyperphagia
,
pregnancy in obesity
,
prader-willi syndrome
,
pre-eclampsia
,
syndrome
,
placenta previa
,
familial primary pulmonary hypertension
,
postpartum hemorrhage
,
hemorrhage
,
obstetric labor complications
,
cesarean section
,
uterine myomectomy
,
myoma
,
uterine inertia
,
leiomyoma
,
pregnancy
,
surgical blood loss
,
myofibroma
,
pregnancy complications
,
anemia
,
cardiac arrhythmias
,
hypersensitivity
,
coronary artery disease
,
myocardial ischemia
,
pregnancy rate
,
pain
,
hyperalgesia
,
central nervous system sensitization
,
placenta accreta
,
anesthesia
,
drug-related side effects and adverse reactions
,
postoperative hemorrhage
,
obesity
,
postoperative pain
Aspartame
liver neoplasms
,
filarial elephantiasis
,
onchocerciasis
,
filariasis
,
elephantiasis
,
healthy volunteers/patients
,
cognitive dysfunction
,
renal cell carcinoma
,
down syndrome
,
syndrome
,
peripheral nervous system diseases
,
small fiber neuropathy
,
carcinoma
,
hepatocellular carcinoma
,
breast neoplasms
,
epilepsy
,
non-small-cell lung carcinoma
,
lung neoplasms
,
myoclonic epilepsies
,
mycoses
,
lymphoma
,
sezary syndrome
,
t-cell lymphoma
,
mycosis fungoides
,
t-cell lymphoma cutaneous
,
neoplasms
,
glandular and epithelial neoplasms
,
brain diseases
,
hepatic encephalopathy
,
alzheimer disease
D-glutamate
colorectal neoplasms
,
lung neoplasms
,
non-small-cell lung carcinoma
,
neoplasms
,
neoplasm metastasis
,
breast neoplasms
,
carcinoma
,
head and neck neoplasms
,
recurrence
,
small cell lung carcinoma
,
adenocarcinoma of lung
,
bronchiolo-alveolar adenocarcinoma
,
prostatic neoplasms
,
ovarian neoplasms
,
pancreatic neoplasms
,
sarcoma
,
ovarian epithelial carcinoma
Fludeoxyglucose f-18
colorectal neoplasms
,
mucinous adenocarcinoma
,
colonic neoplasms
,
adenocarcinoma
,
rectal neoplasms
,
cystadenocarcinoma
,
parkinson disease
,
multiple sclerosis
,
sclerosis
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use